Riskpilot← Back to searchSign inGet full accessOSLO ENDODONTISENTER AS
ASActiveOrg 918164480Sørkedalsveien 10B, 0369 OsloDental practice care activities · NACE 8623Est. 20168 employees
Revenue 2024
NOK 23,2M
+3% vs 2023
EBITDA margin
8.4%
+99% vs 2023
Equity ratio
25.9%
Financial strength
Net profit 2024
NOK 1,3M
+134% vs 2023
| Revenue | NOK 23,2M | +3% |
| EBITDA | NOK 1,9M | +99% |
| Net profit | NOK 1,3M | +134% |
| Total assets | NOK 5,8M | -23% |
| Equity | NOK 1,5M | -36% |
| Employees | 8 | — |
Legal name
OSLO ENDODONTISENTER AS
Org number
918164480
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
8. desember 2016
Share capital
NOK 30 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap
Company purpose
Spesialisert tannlegevirksomhet, deltakelse i annen virksomhet gjennom eierandeler og annen investeringsvirksomhet.
Address
Sørkedalsveien 10B, 0369 Oslo
Phone
+4724076161
Email
post@osloendo.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 17 134 | 21 728 | 16 939 | 22 610 | 23 187 |
| Staff expenses | −2 192 | −2 801 | −2 172 | −3 526 | −3 430 |
| EBITDA | 1 158 | 1 771 | 1 250 | 980 | 1 947 |
| Depreciation & amort. | −104 | −96 | −71 | −308 | −384 |
| EBIT | 1 054 | 1 675 | 1 179 | 672 | 1 563 |
| Net financials | 6 | −1 | −1 | 29 | 90 |
| Profit before tax | 1 059 | 1 675 | 1 179 | 700 | 1 653 |
| Tax | 233 | 370 | 258 | 154 | 372 |
| Net profit | 826 | 1 304 | 920 | 546 | 1 281 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 426 | 5 468 | 7 161 | 7 533 | 5 814 |
| Equity | 2 216 | 3 520 | 3 220 | 2 339 | 1 508 |
| Long-term debt | 2 | 0 | 0 | 4 | 0 |
| Short-term debt | 2 209 | 1 949 | 3 941 | 5 189 | 4 306 |
| Total debt | 2 211 | 1 949 | 3 941 | 5 194 | 4 306 |
EBITDA margin
8.4%
This company
15.8%
Market median
-47% vs market
20202024
Equity ratio
25.9%
This company
38.2%
Market median
-32% vs market
20202024
Return on equity
84.9%
This company
18.4%
Market median
+361% vs market
20202024
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20202024
Asset turnover
3.99×
This company
1.12×
Market median
+256% vs market
20202024
Debt / equity
2.86×
This company
0.62×
Market median
-361% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-09-30
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
TH Chief Executive Officer | Chief Executive Officer | 2016 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2016 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nord Bidco As
OSLO ENDODONTISENTER AS Board members of OSLO ENDODONTISENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Hilmar Myrhaug | Chief Executive Officer | 0 companies |
| Fredrik Grønborg Christensen | Board of Directors | 0 companies |
| Knut Årving | Chairman | 0 companies |
| Margrethe Sunde | Chairman | 0 companies |